These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5153359)

  • 21. [An epidemic episode of poliomyelitis in the City of Taranto. Virological and serological data].
    Mazzotti M; Marchegiani M; Clericò N; Archetii I
    Ann Ist Super Sanita; 1967; 3(3):389-91. PubMed ID: 4309083
    [No Abstract]   [Full Text] [Related]  

  • 22. [Status of antipoliomyelitis immunity in 142 children of the Rieti region from 6 months to 3 years after Sabin vaccination].
    Ferranti P; Realmuto A; Marzetti G; Bertolini L; Assensio Biscogli AM; Balducci L; Midulla M
    Ann Sclavo; 1971; 13(3):332-42. PubMed ID: 5153360
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunity of children and adolescents to poliomyelitis before and after type 3 oral vaccination, and immunity of unvaccinated infants in the Olsztyn Province].
    Rodkiewicz T; Weglińska T
    Przegl Epidemiol; 1972; 26(2):201-4. PubMed ID: 5070976
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 25. [Status of immunity against poliomyelitis in Germany].
    Maass G; Doerr HW
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1670-6. PubMed ID: 3021426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the immunitary condition among children in Savona and the diffusion of poliovirus in the 3 years following mass antipoliomyelitic vaccination].
    Deveris B; De Flora S; Di Stefano G
    G Ig Med Prev; 1968; 9(2):130-41. PubMed ID: 4314815
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliomyelitis surveillance in Kabul City. II.
    Thraenhart O; Omar A; Habib A; Miakhail MR
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):319-24. PubMed ID: 4318511
    [No Abstract]   [Full Text] [Related]  

  • 28. [History and results of a campaign against poliomyelitis].
    Rotta C; Fiandaca S
    Minerva Med; 1967 Aug; 58(61):2755-9. PubMed ID: 6049069
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of complement-fixing antibodies against poliomyelitis in an infantile community of Milan].
    Braga A
    Ann Sclavo; 1971; 13(3):343-52. PubMed ID: 5153361
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oral vaccination against poliomyelitis in the province of Lecce].
    Magliari G; Rubino V
    Ann Sanita Pubblica; 1966; 27(5):1051-70. PubMed ID: 5993987
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epidemiological and immunity aspects of poliomyelitis in children less than a year old in an area in the region of Greater São Paulo, Brazil].
    Waldman EA; Barbosa V; Fujita M; Waldman CC; Gonzaga de Lacerda JP
    Rev Saude Publica; 1983 Feb; 17(1):9-22. PubMed ID: 6867605
    [No Abstract]   [Full Text] [Related]  

  • 32. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroimmunity to polioviruses in an urban population of Italy.
    Volpi A; Ragona G; Biondi W; Rocchi G; Archetti I
    Bull World Health Organ; 1976; 54(3):275-8. PubMed ID: 191208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 35. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
    Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mass trivalent oral polio vaccination in primary school age children in Teheran.
    Nategh R; Naficy K; Shahriary M
    Trop Geogr Med; 1970 Sep; 22(3):303-6. PubMed ID: 5470897
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral poliomyelitis vaccination in the province of Lecce. II].
    Magliari G; Rubino V
    Ann Sanita Pubblica; 1968; 29(4):1021-8. PubMed ID: 5739688
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):653-7. PubMed ID: 5997193
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunity in the population of the Saarland after oral polio vaccination. II. Study on the antibody inauation of 57 orally vaccinated children in the age group of 1 to 6 years].
    Esser I; Keuth U; Wilhelmi J
    Offentl Gesundheitswes; 1971 Jan; 33(1):31-5. PubMed ID: 4250360
    [No Abstract]   [Full Text] [Related]  

  • 40. [Poliomyelitis immunity in the federal republic of Germany in 1969. II].
    Grützner L; Pichl H; Lehmann I; Lenz H
    Zentralbl Bakteriol Orig A; 1971 Jul; 217(3):284-99. PubMed ID: 5572044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.